159 related articles for article (PubMed ID: 21152828)
1. Effects of Trifolium pratense on the climacteric and sexual symptoms in postmenopause women.
del Giorno C; Fonseca AM; Bagnoli VR; Assis JS; Soares JM; Baracat EC
Rev Assoc Med Bras (1992); 2010; 56(5):558-62. PubMed ID: 21152828
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Clinical Meaningfulness of Red Clover (
Kanadys W; Barańska A; Błaszczuk A; Polz-Dacewicz M; Drop B; Kanecki K; Malm M
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33920485
[TBL] [Abstract][Full Text] [Related]
3. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial.
Tice JA; Ettinger B; Ensrud K; Wallace R; Blackwell T; Cummings SR
JAMA; 2003 Jul; 290(2):207-14. PubMed ID: 12851275
[TBL] [Abstract][Full Text] [Related]
4. Effects of a standardised extract of Trifolium pratense (Promensil) at a dosage of 80mg in the treatment of menopausal hot flushes: A systematic review and meta-analysis.
Myers SP; Vigar V
Phytomedicine; 2017 Jan; 24():141-147. PubMed ID: 28160855
[TBL] [Abstract][Full Text] [Related]
5. The effect of oral capsule of curcumin and vitamin E on the hot flashes and anxiety in postmenopausal women: A triple blind randomised controlled trial.
Ataei-Almanghadim K; Farshbaf-Khalili A; Ostadrahimi AR; Shaseb E; Mirghafourvand M
Complement Ther Med; 2020 Jan; 48():102267. PubMed ID: 31987231
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study.
Nahas EA; Nahas-Neto J; Orsatti FL; Carvalho EP; Oliveira ML; Dias R
Maturitas; 2007 Nov; 58(3):249-58. PubMed ID: 17913408
[TBL] [Abstract][Full Text] [Related]
7. Soy isoflavones and melatonin for the relief of climacteric symptoms: a multicenter, double-blind, randomized study.
Secreto G; Chiechi LM; Amadori A; Miceli R; Venturelli E; Valerio T; Marubini E
Maturitas; 2004 Jan; 47(1):11-20. PubMed ID: 14706761
[TBL] [Abstract][Full Text] [Related]
8. The effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women.
Lipovac M; Chedraui P; Gruenhut C; Gocan A; Kurz C; Neuber B; Imhof M
Gynecol Endocrinol; 2012 Mar; 28(3):203-7. PubMed ID: 21870906
[TBL] [Abstract][Full Text] [Related]
9. Red clover extract for alleviating hot flushes in postmenopausal women: a meta-analysis.
Gartoulla P; Han MM
Maturitas; 2014 Sep; 79(1):58-64. PubMed ID: 25074017
[TBL] [Abstract][Full Text] [Related]
10. Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and meta-analysis.
Coon JT; Pittler MH; Ernst E
Phytomedicine; 2007 Feb; 14(2-3):153-9. PubMed ID: 17239573
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
Hudita D; Posea C; Ceausu I; Rusu M
Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
[TBL] [Abstract][Full Text] [Related]
12. The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study.
Hidalgo LA; Chedraui PA; Morocho N; Ross S; San Miguel G
Gynecol Endocrinol; 2005 Nov; 21(5):257-64. PubMed ID: 16373244
[TBL] [Abstract][Full Text] [Related]
13. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study.
Kaari C; Haidar MA; Júnior JM; Nunes MG; Quadros LG; Kemp C; Stavale JN; Baracat EC
Maturitas; 2006 Jan; 53(1):49-58. PubMed ID: 16257151
[TBL] [Abstract][Full Text] [Related]
14. Effect of desvenlafaxine on mood and climacteric symptoms in menopausal women with moderate to severe vasomotor symptoms.
Cheng RJ; Dupont C; Archer DF; Bao W; Racketa J; Constantine G; Pickar JH
Climacteric; 2013 Feb; 16(1):17-27. PubMed ID: 22646219
[TBL] [Abstract][Full Text] [Related]
15. Nonhormonal management of postmenopausal women: effects of a red clover based isoflavones supplementation on climacteric syndrome and cardiovascular risk serum profile.
Mainini G; Torella M; Di Donna MC; Esposito E; Ercolano S; Correa R; Cucinella G; Stradella L; Luisi A; Basso A; Cerreto FV; Cicatiello R; Matteo M; De Franciscis P
Clin Exp Obstet Gynecol; 2013; 40(3):337-41. PubMed ID: 24283160
[TBL] [Abstract][Full Text] [Related]
16. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
Buckler H; Al-Azzawi F;
BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
[TBL] [Abstract][Full Text] [Related]
17. Effect of Trifolium pratense-derived isoflavones on the lipid profile of postmenopausal women with increased body mass index.
Chedraui P; San Miguel G; Hidalgo L; Morocho N; Ross S
Gynecol Endocrinol; 2008 Nov; 24(11):620-4. PubMed ID: 19031218
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of red clover in alleviating menopausal symptoms: a 12-week randomized, controlled trial.
Shakeri F; Taavoni S; Goushegir A; Haghani H
Climacteric; 2015; 18(4):568-73. PubMed ID: 25581426
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
Ziaei S; Moghasemi M; Faghihzadeh S
Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.
Lee BS; Kang BM; Yoon BK; Choi H; Park HM; Kim JG
Maturitas; 2007 Aug; 57(4):361-9. PubMed ID: 17467203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
